Impact of pain and remission in the functioning of patients with depression in Mainland China, Taiwan, and Hong Kong

被引:3
|
作者
Novick, Diego [1 ]
Shi, Qiang [2 ]
Yue, Li [2 ]
Victoria Moneta, Maria [3 ]
Siddi, Sara [3 ,4 ]
Haro, Josep Maria [4 ]
机构
[1] Eli Lilly & Co, Windlesham, Surrey, England
[2] Lilly Suzhou Pharmaceut Co Ltd, Shanghai, Peoples R China
[3] Univ Barcelona, CIBERSAM, Fundacio St Joan de Deu, Parc Sanitari St Joan de Deu, Barcelona, Spain
[4] Univ Cagliari, Dept Educ Psychol & Philosophy, Sect Clin Psychol, Cagliari, Italy
关键词
China; depression; disability; functioning; pain; remission; QUALITY-OF-LIFE; PHYSICAL SYMPTOMS; MAJOR DEPRESSION; LATIN-AMERICA; HELP-SEEKING; DISORDER; PREVALENCE; SEVERITY; COSTS; COMORBIDITY;
D O I
10.1111/appy.12295
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
IntroductionThe present study analyzes functioning during the course of treatment of a major depressive disorder in Mainland China, Taiwan, and Hong Kong. MethodsData in this post hoc analysis were taken from a 24-week prospective, observational study in 12 countries worldwide. Of these, 422 patients were included from Mainland China (N=205; 48.6%), Taiwan (N=199; 47.2%), and Hong Kong (N=18; 4.2%). Functioning was measured with the Sheehan Disability Scale, pain with the Somatic Symptom Inventory, and depression severity with the Quick Inventory of Depressive Symptomatology Self Report 16. Patients were classified as having no pain, persistent pain, or remitted pain. A mixed model with repeated measures was fitted to analyze the relationship between pain and functioning, adjusting for severity and other factors. ResultsAt baseline, 40% of the patients had painful physical symptoms. At 24weeks, 6% of the patients had persistent pain. Sixty percent of the patients achieved remission. Patients with pain had a higher severity of depression score and lower functioning (P<.05) at baseline. At 24weeks, patients with persistent pain had lower functioning (P<.05). The regression model found that clinical remission was associated with higher functioning at endpoint and that patients with persistent pain had lower functioning at endpoint when compared with the no-pain group. ConclusionsPatients presenting with pain had lower functioning at baseline. At 24weeks, pain persistence was associated with significantly lower functioning as measured by the Sheehan Disability Scale. Clinical remission was associated with better functional outcomes. The course of pain was related to achieving remission.
引用
下载
收藏
页数:6
相关论文
共 50 条